FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and cardiology, and can be used for prediction of risk of hospitalizations during a year in patients with ischemic heart disease (IHD). That is ensured by measuring blood serum homocysteine (HC) in mcMol/l, triglycerides (TG) in mmol/l, chaperone activity (CA) in percentage, C-reactive protein (CRP) in mg/ml, as well as the value of systolic blood pressure (SBP) in mm Hg and age in years. Based on the above values, a probability index of hospital admissions of the patient with IHD is calculated in conventional units by formula: IHD = 2.175−0.029*CA−0.159*HC+0.418*CRP−0.129*TG+0.007*SBP+0.013*age. If IHD is more than or equal to 0.46 standard units, a high probability of hospitalization during the next year of follow-up is predicted.
EFFECT: method enables assessing the probability of developing coronary heart disease complications in patients requiring treatment in a hospital setting.
1 cl, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PRESENCE AND MANIFESTATION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2019 |
|
RU2721648C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING ADVERSE CARDIOVASCULAR OUTCOMES WITHIN A YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS WITH STENTING IN PATIENTS WITH STABLE CORONARY HEART DISEASE | 2022 |
|
RU2799146C1 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME IN PATIENTS WITH ACUTE CORONARY SYNDROME AND CONCOMITANT TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2573499C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ADVERSE OUTCOMES WITHIN THE FIRST YEAR FOLLOWING THE PERCUTANEOUS CORONARY INTERVENTION WITH STENTING IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | 2018 |
|
RU2692257C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE | 2021 |
|
RU2762490C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2620545C1 |
| METHOD FOR EVALUATING RISK OF REMOTE DEATH AND NONFATAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2014 |
|
RU2570089C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPING ATHEROSCLEROSIS IN MINERS WITH CHRONIC DUST BRONCHITIS | 2018 |
|
RU2690393C1 |
